(Q38556070)

4 September 2017

1 reference

title

"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa (English)

1 reference

4 September 2017

0 references

1 reference

meningococcal meningitis

1 reference

J B Robbins

1

1 reference

4 September 2017

D W Towne

series ordinal

2

1 reference

4 September 2017

E C Gotschlich

series ordinal

3

1 reference

4 September 2017

R Schneerson

series ordinal

4

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

4 September 2017

1 reference

4 September 2017

volume

350

1 reference

4 September 2017

issue

9081

1 reference

4 September 2017

page(s)

880-882

1 reference

Meningococcal disease and season in sub-Saharan Africa

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Epidemic group A meningococcal disease in Haj pilgrims

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Meningococcal disease due to group A Neisseria meningitidis in contacts of Mecca pilgrims.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Control of epidemic group A meningococcal meningitis in Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Effect of group-A meningococcal vaccine in army recruits in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Group A Meningococcal Polysaccharide Vaccine and Course of the Group A Meningococcal Epidemic in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Prevention of secondary cases of meningococcal disease in household contacts by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Kinetics of Antibody Production to Group A and Group C Meningococcal Polysaccharide Vaccines Administered during the First Six Years of Life: Prospects for Routine Immunization of Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Shift in the age-distribution of meningococcal disease as predictor of an epidemic?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Control of meningococcal infection in the African meningitis belt by selective vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Control of epidemic meningococcal meningitis by mass vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

The 1990 meningococcal meningitis epidemic of Sarh (Chad): how useful was an earlier mass vaccination?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Serum antibodies in six-year-old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

Meningococcal carriage, meningococcal disease and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2903227-3

7 January 2021

10.1016/S0140-6736(97)03227-3

Identifiers

DOI

1 reference

release_b3ri5syj2ffvzf2cjossl2eskm

4 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b3ri5syj2ffvzf2cjossl2eskm

24 November 2022

mapped directly with Wikidata item

1 reference